Scimplify Secures $40M Series B to Revolutionize Sustainable Specialty Chemicals
Scimplify Fuels India’s Green Chemistry Rise
A scientist in a Hyderabad lab refines a biofertilizer to enhance crop yields without degrading soil health, while a factory in Gujarat produces eco-friendly chemicals for a major U.S. pharma company. This is the impact being driven by Scimplify, a Bengaluru-based startup redefining the specialty chemicals industry with sustainability at its core. On March 12, 2025, Scimplify raised $40 million in Series B funding, co-led by Accel and Bertelsmann India Investments, with participation from UMI, Omnivore, and 3one4 Capital, igniting buzz on X and LinkedIn. This brings the total funding to $54 million, following a $9.5 million Series A in August 2024 and a $3.67 million seed round in December 2023. With exports to 16+ countries, a manufacturing network of 200+ factories, and a client base of 600+ companies across life sciences, crop sciences, and industrial chemicals, Scimplify is positioning India as a global powerhouse in green chemistry.
Born in Bengaluru, Going Global
Founded in 2023 by Salil Srivastava, Sachin Santhosh, and Dheeraj Dhingra, Scimplify leverages India’s $180 billion specialty chemicals market—projected to hit $330 billion by 2025—to meet global demand for sustainable solutions. Its plug-and-play platform, ATOMS, connects clients to a vetted network of factories across India, China, Vietnam, and beyond, handling everything from R&D to large-scale production. Serving industries like pharmaceuticals, agrochemicals, and flavors & fragrances, Scimplify’s science-driven approach tackles sourcing, regulatory, and manufacturing challenges, making it a go-to for companies diversifying away from Chinese supply chains.
Scimplify Historical Funding Rounds
Scimplify’s $40 million Series B, announced on March 12, 2025, is a hot topic, with X posts and LinkedIn chatter praising its green chemistry push. Co-led by Accel and Bertelsmann India Investments, the round builds on a strong funding history:
- Seed Round (December 2023): $3.67 million from 3one4 Capital and Beenext launched its B2B platform.
- Series A (August 2024): $9.5 million, led by Omnivore and Bertelsmann, scaled R&D and exports.
- Series B (March 2025): $40 million from Accel, Bertelsmann, UMI, Omnivore, and 3one4 Capital to expand globally and enhance R&D in Hyderabad.
This capital will fuel Scimplify’s expansion into six new countries, targeting a 30–40% quarter-on-quarter growth and $100 million in annualized revenue by mid-2026. Its Hyderabad R&D facility, lauded on LinkedIn, is doubling down on sustainable agrochemicals like Phenmetrazine and bio stimulants, while partnerships with third-party labs broaden its tech offerings.
Real Impact, Real Results
Scimplify’s impact is striking. Its platform cuts production costs by 20–30% for clients by leveraging India’s cost-efficient factories, with mid-sized plants poised to double national output by 2030. Farmers benefit from affordable biofertilizers, boosting yields sustainably, while pharma companies access high-purity APIs faster. Scimplify’s magnesium hydroxide, used in electronics and transportation, aligns with green chemistry’s 12 principles, emitting no toxic gases. Its 600+ clients, including top innovators in the U.S., Europe, and Japan, praise its flexibility, with U.S. firms switching from Chinese suppliers to Scimplify’s seamless solutions. A recent X post highlighted its role in supplying Itraconazole, a key pharmaceutical ingredient, underscoring its life sciences impact.
“We started Scimplify to bring India’s specialized manufacturing to the world,” said Salil Srivastava. “As supply chains shift, clients need R&D-led partners. This funding lets us scale our platform and deliver eco-friendly solutions globally.” Sachin Santhosh added, “Traditional manufacturers are stuck with fixed assets. We’ve built a responsive ecosystem with 200+ plants, tackling any chemical challenge.”
Investor Confidence Soars
Investors are thrilled. “It’s R&D-led network is reshaping specialty chemicals,” said Accel’s Rachit Parekh. “India’s manufacturing depth makes it a global giant in waiting.” Bertelsmann’s Rohit Sood noted, “Their Hyderabad R&D facility and export growth are unmatched, positioning Scimplify to lead global procurement.” Notable angels, including Asish Mohapatra (OfBusiness) and Amrit Acharya (Zetwerk), back its vision.
By the Numbers
Scimplify’s numbers are compelling. India’s specialty chemicals market, growing at a 12% CAGR, outpaces the global 6%. It’s revenue is on track for $100 million by mid-2026, with exports to 16 countries like UAE, Vietnam, and Japan. Its ATOMS platform lists chemicals from 5,000+ factories across 10 countries, vetted semi-annually for compliance. Plans to acquire one or two factories and open U.S. and Japan offices signal bold growth.
A Sustainable Future
Sustainability is Scimplify’s heartbeat. Its R&D follows green chemistry, minimizing waste and energy use. Sourcing prioritizes low-footprint materials, and manufacturing cuts emissions. LinkedIn posts praise its Sciolide, a sustainable musk for perfumes, blending luxury with eco-consciousness. By aligning with India’s manufacturing incentives and global supply chain shifts, Scimplify is capturing a slice of the $800 billion market, with agrochemicals and pharma driving 60%.
This is a story of innovation: the farmer using Scimplify’s biofertilizers, the pharma CEO getting APIs faster, the consumer enjoying safer products. With 150 employees and subsidiaries in Dubai and Indonesia, Scimplify’s platform feels like a global bridge, connecting India’s factories to the world. Its vision—doubling India’s chemical output while staying green—sets a new standard. Scimplify’s mission— “Simplifying sourcing and manufacturing of innovative, sustainable chemicals”—is thriving, one molecule at a time.
Ready to scale your agri startup? Connect with incubators offering funding — Explore Now